RE:Interesting someone mentioned creeper on another board...One player that may fall into that category is our previous debenture holder ATB Capital Markets. Here is a quote from their 2023 cannabis outlook - "we believe investors should focus on operational outperformers with low liquidity risks and valuations below fair industry multiples."
I mentioned previously that I found the entire debenture selloff seemed to be somewhat orchestrated. Having the iceberg continuously in place at 6.5c seems to be very deliberate and based on likely share accumulation and not on flipping. We have 16.7M warrants set to expire on December 22nd 2023. They would represent 13.4% of the total adjusted float if excercised. The vast majority of those warrants are at 27.5c and you would seemingly think there's no way they will be exercised.
If ATB sold there 15M debenture shares into friendly hands, exercised all those warrants and have been accumulating then they could easily have 25%+ of the stock for around 10c per share.
And you missed it.
ATB sets themselves up for a 30% premium takeover bid by one of their other LP cannabis holdings i.e. Aurora or SNDL.
Smart move by the board for shareholder protection (which includes themselves) because a 13c to 14c takeover is not in the majority of shareholders interest.
Something to think about.